Literature DB >> 24912491

Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers.

N D Volkow1, D Tomasi1, G-J Wang2, J Logan2, D L Alexoff2, M Jayne1, J S Fowler2, C Wong1, P Yin3, C Du3.   

Abstract

Dopamine signaling in nucleus accumbens is essential for cocaine reward. Interestingly, imaging studies have reported blunted dopamine increases in striatum (assessed as reduced binding of [(11)C]raclopride to D2/D3 receptors) in detoxified cocaine abusers. Here, we evaluate whether the blunted dopamine response reflected the effects of detoxification and the lack of cocaine-cues during stimulant exposure. For this purpose we studied 62 participants (43 non-detoxified cocaine abusers and 19 controls) using positron emission tomography and [(11)C]raclopride (radioligand sensitive to endogenous dopamine) to measure dopamine increases induced by intravenous methylphenidate and in 24 of the cocaine abusers, we also compared dopamine increases when methylphenidate was administered concomitantly with a cocaine cue-video versus a neutral-video. In controls, methylphenidate increased dopamine in dorsal (effect size 1.4; P<0.001) and ventral striatum (location of accumbens) (effect size 0.89; P<0.001), but in cocaine abusers methylphenidate's effects did not differ from placebo and were similar whether cocaine-cues were present or not. In cocaine abusers despite the markedly attenuated dopaminergic effects, the methylphenidate-induced changes in ventral striatum were associated with intense drug craving. Our findings are consistent with markedly reduced signaling through D2 receptors during intoxication in active cocaine abusers regardless of cues exposure, which might contribute to compulsive drug use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24912491      PMCID: PMC4827430          DOI: 10.1038/mp.2014.58

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  46 in total

Review 1.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  Delays conferred by escalating costs modulate dopamine release to rewards but not their predictors.

Authors:  Matthew J Wanat; Camelia M Kuhnen; Paul E M Phillips
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

4.  Tolerance and sensitization to the effects of cocaine use in humans: a retrospective study of long-term cocaine users in Philadelphia.

Authors:  A C Small; K M Kampman; J Plebani; M De Jesus Quinn; L Peoples; K G Lynch
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

5.  Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Frank Telang; Joanna S Fowler; Kith Pradhan; Millard Jayne; Jean Logan; Rita Z Goldstein; Nelly Alia-Klein; Christopher Wong
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

6.  Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.

Authors:  Buyean Lee; Edythe D London; Russell A Poldrack; Judah Farahi; Angelo Nacca; John R Monterosso; Jeanette A Mumford; Andrew V Bokarius; Magnus Dahlbom; Jogeshwar Mukherjee; Robert M Bilder; Arthur L Brody; Mark A Mandelkern
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

7.  D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats.

Authors:  Panayotis K Thanos; Michael Michaelides; Hiroyuki Umegaki; Nora D Volkow
Journal:  Synapse       Date:  2008-07       Impact factor: 2.562

8.  Cognitive control of drug craving inhibits brain reward regions in cocaine abusers.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Frank Telang; Jean Logan; Millard Jayne; Yeming Ma; Kith Pradhan; Christopher Wong; James M Swanson
Journal:  Neuroimage       Date:  2009-11-11       Impact factor: 6.556

9.  SPECT imaging of striatal dopamine release after amphetamine challenge.

Authors:  M Laruelle; A Abi-Dargham; C H van Dyck; W Rosenblatt; Y Zea-Ponce; S S Zoghbi; R M Baldwin; D S Charney; P B Hoffer; H F Kung
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

10.  Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization.

Authors:  Eisuke Koya; Sam A Golden; Brandon K Harvey; Danielle H Guez-Barber; Alexander Berkow; Danielle E Simmons; Jennifer M Bossert; Sunila G Nair; Jamie L Uejima; Marcelo T Marin; Timothy B Mitchell; David Farquhar; Sukhen C Ghosh; Brandi J Mattson; Bruce T Hope
Journal:  Nat Neurosci       Date:  2009-07-20       Impact factor: 24.884

View more
  48 in total

1.  Hemodynamic and neuronal responses to cocaine differ in awake versus anesthetized animals: Optical brain imaging study.

Authors:  Kicheon Park; Wei Chen; Nora D Volkow; Craig P Allen; Yingtian Pan; Congwu Du
Journal:  Neuroimage       Date:  2018-12-01       Impact factor: 6.556

2.  Dopaminergic system dysfunction in recreational dexamphetamine users.

Authors:  Anouk Schrantee; Lena Václavů; Dennis F R Heijtel; Matthan W A Caan; Willy Gsell; Paul J Lucassen; Aart J Nederveen; Jan Booij; Liesbeth Reneman
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 3.  The striatum: where skills and habits meet.

Authors:  Ann M Graybiel; Scott T Grafton
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-03       Impact factor: 10.005

4.  Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Authors:  Ning-Sheng Cai; César Quiroz; Jordi Bonaventura; Alessandro Bonifazi; Thomas O Cole; Julia Purks; Amy S Billing; Ebonie Massey; Michael Wagner; Eric D Wish; Xavier Guitart; William Rea; Sherry Lam; Estefanía Moreno; Verònica Casadó-Anguera; Aaron D Greenblatt; Arthur E Jacobson; Kenner C Rice; Vicent Casadó; Amy H Newman; John W Winkelman; Michael Michaelides; Eric Weintraub; Nora D Volkow; Annabelle M Belcher; Sergi Ferré
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

5.  Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.

Authors:  K Blum; M Febo; R D Badgaiyan
Journal:  Austin Addict Sci       Date:  2016-10-12

6.  Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.

Authors:  Richard Laforest; Morvarid Karimi; Stephen M Moerlein; Jinbin Xu; Hubert P Flores; Christopher Bognar; Aixiao Li; Robert H Mach; Joel S Perlmutter; Zhude Tu
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

7.  Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.

Authors:  Cody A Siciliano; Kaustuv Saha; Erin S Calipari; Steve C Fordahl; Rong Chen; Habibeh Khoshbouei; Sara R Jones
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

8.  Coordination of Brain-Wide Activity Dynamics by Dopaminergic Neurons.

Authors:  Heather K Decot; Vijay M K Namboodiri; Wei Gao; Jenna A McHenry; Joshua H Jennings; Sung-Ho Lee; Pranish A Kantak; Yu-Chieh Jill Kao; Manasmita Das; Ilana B Witten; Karl Deisseroth; Yen-Yu Ian Shih; Garret D Stuber
Journal:  Neuropsychopharmacology       Date:  2016-08-12       Impact factor: 7.853

9.  Abnormal response to methylphenidate across multiple fMRI procedures in cocaine use disorder: feasibility study.

Authors:  Scott J Moeller; Anna B Konova; Dardo Tomasi; Muhammad A Parvaz; Rita Z Goldstein
Journal:  Psychopharmacology (Berl)       Date:  2016-05-06       Impact factor: 4.530

10.  Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.

Authors:  Cody A Siciliano; Steve C Fordahl; Sara R Jones
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.